Description
Nefazodone is an atypical antidepressant that inhibits 5-HT2 receptors, serotonin transporters (SERT), norepinephrine transporters (NET), and human ether-a-go-go-related (hERG) K+ channels. Nefazodone decreases immobility time in the forced swim test and is clinically used to treat depression, panic disorder, and post-traumatic stress disorder (PTSD).